EMVISION MEDICAL DEVICES LTD - Announcements

3.11%

$1.99

Market Cap $170.1M

Technology Scientific & Technical Instruments

EMVision Medical Devices Limited is an Australian medical device company. The Company is... EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

EMV	Half Year Report & CEO Update	PRICE SENSITIVE	25/02/21	713.78KB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	263.17KB	Share
EMV	FDA Provides De Novo Guidance		25/01/21	198.14KB	Share
EMV	Australian Stroke Alliance & FDA Update		21/12/20	164.99KB	Share
EMV	Change of Principal Place of Business		21/12/20	163.21KB	Share
EMV	Prof Stuart Crozier Appointed as Chief Scientific Officer		17/12/20	169.07KB	Share
EMV	Substantial Shareholder Update		17/12/20	167.85KB	Share
EMV	Ceasing to be a substantial holder		17/12/20	245.85KB	Share
EMV	Appendix 2A - Exercise of Options		17/12/20	292.48KB	Share
EMV	EMVision Receives $1.28M R&D Tax Incentive Rebate for FY20		14/12/20	209.32KB	Share
EMV	Appendix 2A - Exercise of Options		14/12/20	292.47KB	Share
EMV	Appendix 2A - Release of Restricted Securities		14/12/20	291.67KB	Share
EMV	Change of Director's Interest Notice - Correction		14/12/20	326.42KB	Share
EMV	Change of Director's Interest Notice		07/12/20	210.46KB	Share
EMV	Change of Director's Interest Notice		07/12/20	211.98KB	Share
EMV	Appendix 3G - Issue of Options		07/12/20	494.88KB	Share
EMV	Release of Restricted Securities from Escrow		07/12/20	126.15KB	Share
EMV	Change of Director's Interest Notice		03/12/20	176.65KB	Share
EMV	Results of Annual General Meeting		26/11/20	140.93KB	Share
EMV	AGM Chairman's Address & CEO Presentation		26/11/20	1.88MB	Share
EMV	Investor Presentation - Bell Potter Healthcare Conference		25/11/20	2.18MB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/20	269.69KB	Share
EMV	EMVision Reports Very Encouraging Pilot Clinical Trial Data	PRICE SENSITIVE	28/10/20	1005.7KB	Share
EMV	Notice of Annual General Meeting/Proxy Form		27/10/20	719.14KB	Share
EMV	Appendix 3G - Issue of Options		23/10/20	445.16KB	Share
EMV	Date of AGM & Closing Date for Director Nominations		08/10/20	138.51KB	Share
EMV	Change of Director's Interest Notice		02/10/20	176.57KB	Share
EMV	Appendix 3G - Issue of Options		29/09/20	438.3KB	Share
EMV	Final Director's Interest Notice		29/09/20	280.89KB	Share
EMV	Initial Director's Interest Notice		29/09/20	167.87KB	Share
EMV	Dr Philip Dubois Appointed as Non-Executive Director		29/09/20	193.87KB	Share
EMV	EMVision Completes 30 Patient Enrolment	PRICE SENSITIVE	08/09/20	149KB	Share
EMV	Appendix 4G & Corporate Governance Statement		27/08/20	543.52KB	Share
EMV	Appendix 4E & Annual Report 30 June 2020	PRICE SENSITIVE	27/08/20	4.08MB	Share
EMV	Advance QLD Industry Fellowship Win		25/08/20	171.76KB	Share
EMV	EMVision Appoints Head of Program Management		12/08/20	141.22KB	Share
EMV	Appendix 4C- quarterly - Additional Information	PRICE SENSITIVE	06/08/20	172.32KB	Share
EMV	Change in substantial holding		05/08/20	180.73KB	Share
EMV	Auditor Resignation & Appointment		04/08/20	180.96KB	Share
EMV	Ceasing to be a substantial holder		31/07/20	219.37KB	Share
EMV	Change in substantial holding		31/07/20	176.79KB	Share
EMV	Appendix 2A & Cleansing Notice - Placement		30/07/20	405.53KB	Share
EMV	EMVision Receives Binding Commitments for $9M Placement	PRICE SENSITIVE	24/07/20	186.75KB	Share
EMV	Proposed issue of Securities - EMV	PRICE SENSITIVE	24/07/20	25.23KB	Share
EMV	Trading Halt	PRICE SENSITIVE	22/07/20	393.34KB	Share
EMV	Encouraging Haemorrhagic Images with Classification	PRICE SENSITIVE	22/07/20	790.73KB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	22/07/20	297.13KB	Share
EMV	Appendix 3G - Issue of Options		03/07/20	439.79KB	Share
EMV	Appendix 2A & Cleansing Notice - Exercise of Options		03/07/20	415.3KB	Share
EMV	Investor Presentation		25/06/20	2.52MB	Share
EMV	Appendix 2A & Cleansing Notice		16/06/20	411.94KB	Share
EMV	Release of Restricted Securities from Escrow		09/06/20	125.64KB	Share
EMV	Clinical Trial Enrolment Recommences	PRICE SENSITIVE	14/05/20	182.5KB	Share
EMV	Initial Director's Interest Notice		06/05/20	154.61KB	Share
EMV	Dr Ron Weinberger Appointed Managing Director	PRICE SENSITIVE	06/05/20	148.67KB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/20	242.11KB	Share
EMV	Promising First Stroke Patient Images From Clinical Trial	PRICE SENSITIVE	21/04/20	501.43KB	Share
EMV	Clinical Trial Update	PRICE SENSITIVE	02/04/20	138.37KB	Share
EMV	Clinical Trial Update	PRICE SENSITIVE	25/03/20	141.34KB	Share
EMV	Half Year Report & CEO Update	PRICE SENSITIVE	27/02/20	536.72KB	Share
EMV	Advance QLD Industry Fellowship Wins		20/02/20	170.93KB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/20	350.91KB	Share
EMV	EMVision Commences Clinical Trial	PRICE SENSITIVE	29/01/20	181.74KB	Share
EMV	Entry Into Clinic Achieved	PRICE SENSITIVE	19/12/19	152.76KB	Share
EMV	Amended Constitution		04/12/19	556.07KB	Share
EMV	Results of Annual General Meeting		26/11/19	187.47KB	Share
EMV	AGM Address & Presentation		26/11/19	1.56MB	Share
EMV	Appendix 3B & Cleansing Notice		13/11/19	525.24KB	Share
EMV	EMVision Completes $4.5M Placement	PRICE SENSITIVE	05/11/19	140.86KB	Share
EMV	Trading Halt	PRICE SENSITIVE	01/11/19	231.79KB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/19	337.24KB	Share
EMV	EMVision Completes First Clinical Unit Targeting Stroke	PRICE SENSITIVE	31/10/19	4.64MB	Share
EMV	Notice of Annual General Meeting/Proxy Form		25/10/19	608.46KB	Share
EMV	Response to ASX Price Query	PRICE SENSITIVE	09/10/19	265.61KB	Share
EMV	Trading Halt Request		09/10/19	136.89KB	Share
EMV	Trading Halt	PRICE SENSITIVE	09/10/19	72.15KB	Share
EMV	Pause In Trading	PRICE SENSITIVE	09/10/19	115.92KB	Share
EMV	On Target For Trial To Commence Q4 Calendar 2019	PRICE SENSITIVE	03/09/19	597.63KB	Share
EMV	Appendix 4G & Corporate Governance Statement		30/08/19	362.98KB	Share
EMV	Appendix 4E & Annual Report 30 June 2019	PRICE SENSITIVE	30/08/19	1.01MB	Share
EMV	Bioshares Biotech Summit Presentation		25/07/19	2.19MB	Share
EMV	Investor Presentation		25/07/19	2.45MB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	23/07/19	266.56KB	Share
EMV	Release of Restricted Securities from Escrow		08/07/19	125.68KB	Share
EMV	Appendix 3B		05/07/19	324.77KB	Share
EMV	EMvision Appoints Head of Quality & Regulatory Affairs		03/07/19	180.06KB	Share
EMV	Brain Scanner Development Update	PRICE SENSITIVE	01/07/19	407.3KB	Share
EMV	EMvision Appoints Clinical Advisory Board		12/06/19	370.96KB	Share
EMV	Change of Director's Interest Notice		05/06/19	177.51KB	Share
EMV	Australian Stoke Alliance Successful in Frontiers Bid		22/05/19	138.32KB	Share
EMV	Appendix 3B Release of Restricted Securities		30/04/19	256.73KB	Share
EMV	Strategic Collaboration with Keysight Technologies	PRICE SENSITIVE	30/04/19	711.1KB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	15/04/19	265.22KB	Share
EMV	Release of Restricted Securities from Escrow		10/04/19	141.23KB	Share
EMV	EMvision Secures Ethics Approval for Pilot Clinical Trial	PRICE SENSITIVE	27/03/19	412.15KB	Share
EMV	EMvision Invited to Join Australian Stroke Alliance		18/03/19	226.65KB	Share
EMV	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/19	433.78KB	Share
EMV	Investor Presentation		05/02/19	11.95MB	Share
EMV	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/19	302.44KB	Share
EMV	Positive Safety Observations from Healthy Human Trials	PRICE SENSITIVE	24/01/19	182.94KB	Share

EMV Half Year Report & CEO Update
25/02/21	PRICE SENSITIVE	713.78KB	Share
EMV Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	263.17KB	Share
EMV FDA Provides De Novo Guidance
25/01/21		198.14KB	Share
EMV Australian Stroke Alliance & FDA Update
21/12/20		164.99KB	Share
EMV Change of Principal Place of Business
21/12/20		163.21KB	Share
EMV Prof Stuart Crozier Appointed as Chief Scientific Officer
17/12/20		169.07KB	Share
EMV Substantial Shareholder Update
17/12/20		167.85KB	Share
EMV Ceasing to be a substantial holder
17/12/20		245.85KB	Share
EMV Appendix 2A - Exercise of Options
17/12/20		292.48KB	Share
EMV EMVision Receives $1.28M R&D Tax Incentive Rebate for FY20
14/12/20		209.32KB	Share
EMV Appendix 2A - Exercise of Options
14/12/20		292.47KB	Share
EMV Appendix 2A - Release of Restricted Securities
14/12/20		291.67KB	Share
EMV Change of Director's Interest Notice - Correction
14/12/20		326.42KB	Share
EMV Change of Director's Interest Notice
07/12/20		210.46KB	Share
EMV Change of Director's Interest Notice
07/12/20		211.98KB	Share
EMV Appendix 3G - Issue of Options
07/12/20		494.88KB	Share
EMV Release of Restricted Securities from Escrow
07/12/20		126.15KB	Share
EMV Change of Director's Interest Notice
03/12/20		176.65KB	Share
EMV Results of Annual General Meeting
26/11/20		140.93KB	Share
EMV AGM Chairman's Address & CEO Presentation
26/11/20		1.88MB	Share
EMV Investor Presentation - Bell Potter Healthcare Conference
25/11/20		2.18MB	Share
EMV Appendix 4C - quarterly
30/10/20	PRICE SENSITIVE	269.69KB	Share
EMV EMVision Reports Very Encouraging Pilot Clinical Trial Data
28/10/20	PRICE SENSITIVE	1005.7KB	Share
EMV Notice of Annual General Meeting/Proxy Form
27/10/20		719.14KB	Share
EMV Appendix 3G - Issue of Options
23/10/20		445.16KB	Share
EMV Date of AGM & Closing Date for Director Nominations
08/10/20		138.51KB	Share
EMV Change of Director's Interest Notice
02/10/20		176.57KB	Share
EMV Appendix 3G - Issue of Options
29/09/20		438.3KB	Share
EMV Final Director's Interest Notice
29/09/20		280.89KB	Share
EMV Initial Director's Interest Notice
29/09/20		167.87KB	Share
EMV Dr Philip Dubois Appointed as Non-Executive Director
29/09/20		193.87KB	Share
EMV EMVision Completes 30 Patient Enrolment
08/09/20	PRICE SENSITIVE	149KB	Share
EMV Appendix 4G & Corporate Governance Statement
27/08/20		543.52KB	Share
EMV Appendix 4E & Annual Report 30 June 2020
27/08/20	PRICE SENSITIVE	4.08MB	Share
EMV Advance QLD Industry Fellowship Win
25/08/20		171.76KB	Share
EMV EMVision Appoints Head of Program Management
12/08/20		141.22KB	Share
EMV Appendix 4C- quarterly - Additional Information
06/08/20	PRICE SENSITIVE	172.32KB	Share
EMV Change in substantial holding
05/08/20		180.73KB	Share
EMV Auditor Resignation & Appointment
04/08/20		180.96KB	Share
EMV Ceasing to be a substantial holder
31/07/20		219.37KB	Share
EMV Change in substantial holding
31/07/20		176.79KB	Share
EMV Appendix 2A & Cleansing Notice - Placement
30/07/20		405.53KB	Share
EMV EMVision Receives Binding Commitments for $9M Placement
24/07/20	PRICE SENSITIVE	186.75KB	Share
EMV Proposed issue of Securities - EMV
24/07/20	PRICE SENSITIVE	25.23KB	Share
EMV Trading Halt
22/07/20	PRICE SENSITIVE	393.34KB	Share
EMV Encouraging Haemorrhagic Images with Classification
22/07/20	PRICE SENSITIVE	790.73KB	Share
EMV Appendix 4C - quarterly
22/07/20	PRICE SENSITIVE	297.13KB	Share
EMV Appendix 3G - Issue of Options
03/07/20		439.79KB	Share
EMV Appendix 2A & Cleansing Notice - Exercise of Options
03/07/20		415.3KB	Share
EMV Investor Presentation
25/06/20		2.52MB	Share
EMV Appendix 2A & Cleansing Notice
16/06/20		411.94KB	Share
EMV Release of Restricted Securities from Escrow
09/06/20		125.64KB	Share
EMV Clinical Trial Enrolment Recommences
14/05/20	PRICE SENSITIVE	182.5KB	Share
EMV Initial Director's Interest Notice
06/05/20		154.61KB	Share
EMV Dr Ron Weinberger Appointed Managing Director
06/05/20	PRICE SENSITIVE	148.67KB	Share
EMV Appendix 4C - quarterly
30/04/20	PRICE SENSITIVE	242.11KB	Share
EMV Promising First Stroke Patient Images From Clinical Trial
21/04/20	PRICE SENSITIVE	501.43KB	Share
EMV Clinical Trial Update
02/04/20	PRICE SENSITIVE	138.37KB	Share
EMV Clinical Trial Update
25/03/20	PRICE SENSITIVE	141.34KB	Share
EMV Half Year Report & CEO Update
27/02/20	PRICE SENSITIVE	536.72KB	Share
EMV Advance QLD Industry Fellowship Wins
20/02/20		170.93KB	Share
EMV Appendix 4C - quarterly
30/01/20	PRICE SENSITIVE	350.91KB	Share
EMV EMVision Commences Clinical Trial
29/01/20	PRICE SENSITIVE	181.74KB	Share
EMV Entry Into Clinic Achieved
19/12/19	PRICE SENSITIVE	152.76KB	Share
EMV Amended Constitution
04/12/19		556.07KB	Share
EMV Results of Annual General Meeting
26/11/19		187.47KB	Share
EMV AGM Address & Presentation
26/11/19		1.56MB	Share
EMV Appendix 3B & Cleansing Notice
13/11/19		525.24KB	Share
EMV EMVision Completes $4.5M Placement
05/11/19	PRICE SENSITIVE	140.86KB	Share
EMV Trading Halt
01/11/19	PRICE SENSITIVE	231.79KB	Share
EMV Appendix 4C - quarterly
31/10/19	PRICE SENSITIVE	337.24KB	Share
EMV EMVision Completes First Clinical Unit Targeting Stroke
31/10/19	PRICE SENSITIVE	4.64MB	Share
EMV Notice of Annual General Meeting/Proxy Form
25/10/19		608.46KB	Share
EMV Response to ASX Price Query
09/10/19	PRICE SENSITIVE	265.61KB	Share
EMV Trading Halt Request
09/10/19		136.89KB	Share
EMV Trading Halt
09/10/19	PRICE SENSITIVE	72.15KB	Share
EMV Pause In Trading
09/10/19	PRICE SENSITIVE	115.92KB	Share
EMV On Target For Trial To Commence Q4 Calendar 2019
03/09/19	PRICE SENSITIVE	597.63KB	Share
EMV Appendix 4G & Corporate Governance Statement
30/08/19		362.98KB	Share
EMV Appendix 4E & Annual Report 30 June 2019
30/08/19	PRICE SENSITIVE	1.01MB	Share
EMV Bioshares Biotech Summit Presentation
25/07/19		2.19MB	Share
EMV Investor Presentation
25/07/19		2.45MB	Share
EMV Appendix 4C - quarterly
23/07/19	PRICE SENSITIVE	266.56KB	Share
EMV Release of Restricted Securities from Escrow
08/07/19		125.68KB	Share
EMV Appendix 3B
05/07/19		324.77KB	Share
EMV EMvision Appoints Head of Quality & Regulatory Affairs
03/07/19		180.06KB	Share
EMV Brain Scanner Development Update
01/07/19	PRICE SENSITIVE	407.3KB	Share
EMV EMvision Appoints Clinical Advisory Board
12/06/19		370.96KB	Share
EMV Change of Director's Interest Notice
05/06/19		177.51KB	Share
EMV Australian Stoke Alliance Successful in Frontiers Bid
22/05/19		138.32KB	Share
EMV Appendix 3B Release of Restricted Securities
30/04/19		256.73KB	Share
EMV Strategic Collaboration with Keysight Technologies
30/04/19	PRICE SENSITIVE	711.1KB	Share
EMV Appendix 4C - quarterly
15/04/19	PRICE SENSITIVE	265.22KB	Share
EMV Release of Restricted Securities from Escrow
10/04/19		141.23KB	Share
EMV EMvision Secures Ethics Approval for Pilot Clinical Trial
27/03/19	PRICE SENSITIVE	412.15KB	Share
EMV EMvision Invited to Join Australian Stroke Alliance
18/03/19		226.65KB	Share
EMV Half Yearly Report and Accounts
26/02/19	PRICE SENSITIVE	433.78KB	Share
EMV Investor Presentation
05/02/19		11.95MB	Share
EMV Appendix 4C - quarterly
30/01/19	PRICE SENSITIVE	302.44KB	Share
EMV Positive Safety Observations from Healthy Human Trials
24/01/19	PRICE SENSITIVE	182.94KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.99		Change 0.060(3.11%)		Mkt cap ! $170.1M

Open	High	Low	Value	Volume
$1.92	$2.01	$1.92	$83.25K	42.04K

Buyers (Bids)

No.	Vol.	Price($)
1	6	$1.99

Sellers (Offers)

Price($)	Vol.	No.
$2.01	5902	1

View Market Depth

No.	Vol.	Price($)
1	1000	1.980
1	1382	1.975
2	8052	1.970
1	4000	1.960
1	12000	1.900

Price($)	Vol.	No.
2.010	5902	1
2.020	10000	1
2.040	1960	1
2.060	3136	1
2.080	23312	1

Last trade - 16.10pm 05/09/2025 (20 minute delay)

EMV (ASX) Chart

EMVISION MEDICAL DEVICES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories